M&A Deal Summary

CoreRx Acquires Societal CDMO

On April 8, 2024, CoreRx acquired life science company Societal CDMO for 130M USD

Acquisition Highlights
  • This is CoreRx’s 1st transaction in the Life Science sector.
  • This is CoreRx’s largest (disclosed) transaction.
  • This is CoreRx’s 1st transaction in the United States.
  • This is CoreRx’s 1st transaction in Georgia.

M&A Deal Summary
Date 2024-04-08
Target Societal CDMO
Sector Life Science
Buyer(s) CoreRx
Deal Type Add-on Acquisition
Deal Value 130M USD
Advisor(s) Raymond James - Investment Banking (Financial)
Goodwin Procter (Legal)

Target

Societal CDMO

Gainesville, Georgia, United States
Societal CDMO is a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products. Societal CDMO was formed in 2007 and is based in Gainesville, Georgia.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CoreRx

Clearwater, Florida, United States
Category Company
Founded 2006
Sector Life Science
DESCRIPTION

CoreRx is a provider of clinical and commercial CDMO services to a wide range of small to mid-sized pharmaceutical and biotech clients. CoreRx was founded in 2006 and is based in Clearwater, Florida.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Georgia) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal